Preparation and diagnostic use of recombinant proteins derived from early antigen (EA) of Epstein-Barr virus (EBV).
Public support
Provider
Ministry of Industry and Trade
Programme
—
Call for proposals
SMPO_00_FB-C3
Main participants
VIDIA spol. s r.o.
Contest type
VS - Public tender
Contract ID
—
Alternative language
Project name in Czech
Příprava a diagnostické využití rekombinantních proteinů odvozených od časného antigenu (EA) viru Epsteina a Barrové (EBV).
Annotation in Czech
Cílem projektu je příprava a využití rekombinantních proteinů odvozených od proteinů komplexu časného antigenu (EA) viru Epsteina a Barrové (EVB), které mají značný význam pro diferenciální diagnostiku chorob vyvolaných nebo asociovaných s tímto virem
Scientific branches
R&D category
—
CEP classification - main branch
EI - Biotechnology and bionics
CEP - secondary branch
EE - Microbiology, virology
CEP - another secondary branch
—
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
10606 - Microbiology<br>10607 - Virology<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
Cíle a věcná náplň předmětného projektu byly splněny ve stanoveném rozsahu a termínech.
Solution timeline
Realization period - beginning
Jan 1, 2000
Realization period - end
Jan 1, 2002
Project status
U - Finished project
Latest support payment
—
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP/2003/MPO/MPO3FB/U/N/5:2
Data delivery date
Feb 3, 2004
Finance
Total approved costs
6,297 thou. CZK
Public financial support
2,999 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
3,297 thou. CZK